[go: up one dir, main page]

CA2026885A1 - Interface pour l'iontophorese - Google Patents

Interface pour l'iontophorese

Info

Publication number
CA2026885A1
CA2026885A1 CA 2026885 CA2026885A CA2026885A1 CA 2026885 A1 CA2026885 A1 CA 2026885A1 CA 2026885 CA2026885 CA 2026885 CA 2026885 A CA2026885 A CA 2026885A CA 2026885 A1 CA2026885 A1 CA 2026885A1
Authority
CA
Canada
Prior art keywords
iontophorese
interface
drug
supplementing water
semipermeable membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2026885
Other languages
English (en)
Other versions
CA2026885C (fr
Inventor
Keiichirou Okabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2584289A external-priority patent/JP2792660B2/ja
Priority claimed from JP2584389A external-priority patent/JP2792661B2/ja
Priority claimed from JP22316689A external-priority patent/JP2798272B2/ja
Priority claimed from JP23149789A external-priority patent/JP2845509B2/ja
Application filed by Individual filed Critical Individual
Publication of CA2026885A1 publication Critical patent/CA2026885A1/fr
Application granted granted Critical
Publication of CA2026885C publication Critical patent/CA2026885C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0444—Membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Electrotherapy Devices (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

Cette invention concerne une interface pour ionophorèse formée d'une couche réservoir d'eau d'appoint, d'une couche réservoir de médicament composée d'une membrane semi-perméable et d'un matériau poreux rigide ou d'un gel sur substrat, ou d'une couche réservoir d'eau d'appoint combinée à une membrane semi-perméable ou permsélective enduite de médicament ou retenant un médicament, l'interface étant destinée à être appliquée sur la peau.
CA 2026885 1989-02-06 1990-02-06 Interface pour l'iontophorese Expired - Fee Related CA2026885C (fr)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP1-25843 1989-02-06
JP1-25842 1989-02-06
JP2584289A JP2792660B2 (ja) 1989-02-06 1989-02-06 イオントフォレーゼ用インタフェース
JP2584389A JP2792661B2 (ja) 1989-02-06 1989-02-06 イオントフォレーゼ用インタフェース
JP22316689A JP2798272B2 (ja) 1989-08-31 1989-08-31 イオントフォレーゼ用インタフェース
JP1-223166 1989-08-31
JP23149789A JP2845509B2 (ja) 1989-09-08 1989-09-08 イオントフォレーゼ用インタフェース
JP1-231497 1989-09-08

Publications (2)

Publication Number Publication Date
CA2026885A1 true CA2026885A1 (fr) 1990-08-07
CA2026885C CA2026885C (fr) 1998-12-01

Family

ID=27458390

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2026885 Expired - Fee Related CA2026885C (fr) 1989-02-06 1990-02-06 Interface pour l'iontophorese

Country Status (5)

Country Link
EP (1) EP0411146B1 (fr)
AU (1) AU624481B2 (fr)
CA (1) CA2026885C (fr)
DE (1) DE69026323T2 (fr)
WO (1) WO1990008571A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019068288A1 (fr) 2017-10-04 2019-04-11 Berlimed International Research Gmbh Produit contenant un principe actif et une matrice de principe actif pour administrer par voie transdermique le principe actif, sa fabrication et son utilisation et matrice de principe actif, sa fabrication et son utilisation

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2095929T3 (es) * 1989-10-23 1997-03-01 Theratech Inc Dispositivo iontoforetico que emplea un regulador del regimen.
ES2072134T3 (es) * 1990-10-29 1995-07-01 Alza Corp Electrodo iontoforetico para suministrar farmacos y metodo para su hidratacion.
US5158537A (en) * 1990-10-29 1992-10-27 Alza Corporation Iontophoretic delivery device and method of hydrating same
US5415629A (en) * 1993-09-15 1995-05-16 Henley; Julian L. Programmable apparatus for the transdermal delivery of drugs and method
DE69630918T2 (de) 1995-06-09 2004-10-28 Hisamitsu Pharmaceutical Co., Inc., Tosu Matrix für Iontophorese
ATE248004T1 (de) 1995-06-14 2003-09-15 Hisamitsu Pharmaceutical Co Schnittstelle für iontophorese
WO1997012644A1 (fr) * 1995-09-29 1997-04-10 Becton Dickinson And Company Reservoir iontophoretique ameliore
US5908400A (en) * 1996-06-20 1999-06-01 Hisamitsu Pharmaceutical Co., Inc. Device structure for iontophoresis
US6148231A (en) 1998-09-15 2000-11-14 Biophoretic Therapeutic Systems, Llc Iontophoretic drug delivery electrodes and method
FI107372B (fi) * 1999-04-29 2001-07-31 Novagent Oy Laite vaikuttavan aineen annosteluun ja annostelun tutkimukseen
US7590444B2 (en) 2004-12-09 2009-09-15 Tti Ellebeau, Inc. Iontophoresis device
JP4731931B2 (ja) 2005-02-03 2011-07-27 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
JP4793806B2 (ja) 2005-03-22 2011-10-12 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
US8386030B2 (en) 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US8295922B2 (en) 2005-08-08 2012-10-23 Tti Ellebeau, Inc. Iontophoresis device
CA2671069A1 (fr) 2006-12-01 2008-06-12 Tti Ellebeau, Inc. Systemes, dispositifs et procedes permettant d'alimenter et/ou de controler des dispositifs, par exemple des dispositifs d'application transdermique
FR2936714B1 (fr) * 2008-10-02 2016-06-24 Oreal Procede de traitement cosmetique et ensemble pour la mise en oeuvre d'un tel procede
US20140120144A1 (en) * 2011-06-14 2014-05-01 Nanotheta CO., LTD. Thin Film Supporting Hyaluronic Acid Or Derivative Thereof And Thin Film Cosmetic

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1262564A (fr) * 1983-09-01 1989-10-31 Minoru Sasaki Dispositif d'iontophorese
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
JPS62268569A (ja) * 1986-05-19 1987-11-21 株式会社アドバンス イオントフオレ−ゼ用リザ−バ電極
DE3775830D1 (de) * 1986-06-13 1992-02-20 Alza Corp Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
JPS63102768A (ja) * 1986-10-20 1988-05-07 山之内製薬株式会社 イオントフオレ−シス用の新規プラスタ−構造体
US4731049A (en) * 1987-01-30 1988-03-15 Ionics, Incorporated Cell for electrically controlled transdermal drug delivery

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019068288A1 (fr) 2017-10-04 2019-04-11 Berlimed International Research Gmbh Produit contenant un principe actif et une matrice de principe actif pour administrer par voie transdermique le principe actif, sa fabrication et son utilisation et matrice de principe actif, sa fabrication et son utilisation

Also Published As

Publication number Publication date
CA2026885C (fr) 1998-12-01
EP0411146A4 (en) 1992-05-06
DE69026323D1 (de) 1996-05-09
WO1990008571A1 (fr) 1990-08-09
DE69026323T2 (de) 1996-10-24
AU5032790A (en) 1990-08-24
AU624481B2 (en) 1992-06-11
EP0411146B1 (fr) 1996-04-03
EP0411146A1 (fr) 1991-02-06

Similar Documents

Publication Publication Date Title
CA2026885A1 (fr) Interface pour l'iontophorese
AU7729087A (en) Plugged microporous film
AU569660B2 (en) Molecular layer electrode with glucose permeable membrane
DE3272203D1 (en) Absorbent body with semipermeable membrane
EP0748636A3 (fr) Interface pour iontophorèse
EP0430082A3 (en) Porous membrane formed from an interpenetrating polymer network having hydrophilic surface
DE68907406D1 (de) Deprenyl zur systemischen transdermalen anwendung.
GB2235690B (en) Hydrophilic semi-permeable ptfe membranes and their manufacture
EP0190558A3 (en) Hydrophilic porous membrane and method for manufacture thereof
JPS57185870A (en) Applicator of pharmacologically active drug, production and use thereof
YU126287A (en) Differential pressure probe with shaped membrane
FR2631247B1 (fr) Membrane semi-permeable tres selective et hydrophile en surface
GB2103536B (en) Composite hydrophilic semipermeable membrane
EP0186758A3 (en) Porous membrane having hydrophilic surface and process of its manufacture
EP0381757A4 (en) Medical instrument and production thereof
DE69009450D1 (de) Poröser kohlenstoffkörper mit flachen blattförmigen rippen und herstellungsverfahren.
FR2625217B1 (fr) Composition d'adhesif active sous l'effet de la pression a base de copolymere acrylique
CA2031393A1 (fr) Comprimes a liberation progressive de substances actives
AU521361B2 (en) Device for the transcutaneous electrochemical determination of the partial oxygen pressure in blood
CA2023152A1 (fr) Materiau composite utilisable en medecine
EP0070268A3 (fr) Agencement de surface prévu pour le contact avec la peau humaine
USD274452S (en) Water reservoir for a reverse osmosis system
AU2934389A (en) Hollow fiber membrane and fluid processor using the same
EP0228248A3 (fr) Membranes composites semi-perméables
USD273976S (en) Water reservoir for a reverse osmosis system

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed